Robbins Farley Has $1.48 Million Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Robbins Farley increased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 5.0% during the fourth quarter, HoldingsChannel reports. The fund owned 4,940 shares of the company’s stock after acquiring an additional 234 shares during the quarter. Robbins Farley’s holdings in HCA Healthcare were worth $1,483,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also recently bought and sold shares of the stock. Financial Strategies Group Inc. grew its position in HCA Healthcare by 17.3% during the fourth quarter. Financial Strategies Group Inc. now owns 23,694 shares of the company’s stock worth $7,175,000 after buying an additional 3,495 shares in the last quarter. U.S. Capital Wealth Advisors LLC grew its holdings in shares of HCA Healthcare by 11.5% during the 4th quarter. U.S. Capital Wealth Advisors LLC now owns 2,951 shares of the company’s stock worth $886,000 after purchasing an additional 305 shares in the last quarter. Greenleaf Trust lifted its position in HCA Healthcare by 0.8% in the fourth quarter. Greenleaf Trust now owns 5,771 shares of the company’s stock worth $1,732,000 after purchasing an additional 46 shares during the period. Spire Wealth Management increased its holdings in HCA Healthcare by 23.0% in the 4th quarter. Spire Wealth Management now owns 9,913 shares of the company’s stock valued at $2,975,000 after buying an additional 1,851 shares during the period. Finally, DAVENPORT & Co LLC lifted its holdings in shares of HCA Healthcare by 1.9% during the 4th quarter. DAVENPORT & Co LLC now owns 11,333 shares of the company’s stock worth $3,402,000 after acquiring an additional 214 shares during the period. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Trading Up 1.4 %

HCA Healthcare stock opened at $334.65 on Tuesday. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The stock has a market capitalization of $84.77 billion, a P/E ratio of 15.23, a PEG ratio of 1.13 and a beta of 1.64. The stock has a 50-day simple moving average of $313.33 and a 200 day simple moving average of $353.50. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter in the previous year, the business earned $5.90 earnings per share. Analysts expect that HCA Healthcare, Inc. will post 24.89 earnings per share for the current year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be paid a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.86%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio (DPR) is 12.02%.

Analyst Upgrades and Downgrades

HCA has been the topic of several recent analyst reports. JPMorgan Chase & Co. restated a “neutral” rating and issued a $380.00 target price on shares of HCA Healthcare in a research note on Tuesday, December 17th. TD Cowen decreased their price objective on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research note on Monday, October 28th. Raymond James downgraded HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. Oppenheimer lifted their price objective on HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research report on Monday, October 28th. Finally, StockNews.com lowered HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. One research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and a consensus price target of $385.67.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the transaction, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the sale, the insider now owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.70% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.